Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-10-28 | Monte Rosa Therapeutics, Inc. | Versant Vantage I...
(AtLeastTenPercentOwner) |
S | Common Stock | D | 157895 | $9.08 - $9.66 | $1,491,039 |
| 2024-10-28 | Monte Rosa Therapeutics, Inc. | Versant Vantage I...
(AtLeastTenPercentOwner) |
J | Common Stock | D | 1484347 | $0.00 - $0.00 | $0 |
| 2024-09-20 | Monte Rosa Therapeutics, Inc. | Versant Vantage I...
(AtLeastTenPercentOwner) |
S | Common Stock | D | 1132566 | $6.53 - $6.53 | $7,395,202 |
| 2024-09-11 | Monte Rosa Therapeutics, Inc. | Versant Vantage I...
(AtLeastTenPercentOwner) |
S | Common Stock | D | 567213 | $6.00 - $6.16 | $3,404,790 |
| 2024-07-05 | Monte Rosa Therapeutics, Inc. | Dunn Edmund
(Principal Accounting Officer) |
S | Common Stock | D | 1610 | $3.83 - $3.83 | $6,166 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |